A prospective randomized trial on mycophenolate mofetil in risk penetrating keratoplasty
Phase of Trial: Phase IV
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Keratoplasty rejection
- Focus Therapeutic Use
- 12 Jul 2012 Additional trial identifier 116-00 identified as reported by German Clinical Trials Register.
- 25 Aug 2011 Actual initiation date (13 Sep 2000) added as reported by German Clinical Trials Register.
- 25 Aug 2011 New source identified and integrated (German Clinical Trials Register DRKS00000011).